The G2 spray cryotherapy device was introduced to the market in 2007 for endoscopic ablation and has since been adopted in clinical practice at leading healthcare facilities across the country. Based on customer feedback and utilization of the G2 device, CSA Medical developed the new truFreeze System.The truFreeze System is CSA Medicals latest advance in spray cryotherapy technology. The device uses a patented technology to deliver extremely cold (-196 C) liquid nitrogen through a small catheter to produce touch-less flash freezing of a variety of tissue surfaces. During this process, cells are selectively destroyed while the underlying collagen tissue structure is preserved providing a scaffold for healthy tissue to re-grow.
Product URL : http://csamedical.com/trufreeze/
Last Updated : 03/16/2013